Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.
Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
Small form factor flow virometer for SARS-CoV-2.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors.
Rate and predictors of progression in elite and viremic HIV-1 controllers.
Identification of a cluster of HIV-1 controllers infected with low replicating viruses.
Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers.
Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals.